Timing of Initiation of First-line Antiretroviral Therapy
Summary
- Data from the SMART study, HPTN 052, the CHER trial, CIPRA HT001 trial, TEMPRANO trial, and the START trial support earlier ART initiation at higher CD4+ counts (Table 3)[Grinsztejn 2014; SMART 2006; SMART 2008a; SMART 2008b; Cohen 2011; Violari 2008; Severe 2010; TEMPRANO 2015; INSIGHT START 2015]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy